Epidemiology and Etiology of Premalignant and Malignant Urothelial Changes

REFERENCES

• Johansson SL, Cohen SM. Pathology of bladder cancer. In: Raghaven D, Scher M, Leibel SA, Lange PH, eds. Principles and practice of genitourinary oncology. Philadelphia, PA: Lippincott-Raven, 1997: 207–13.
   Google Scholar
• Epstein JI, Amin MB, Reuter VR, Mostofi FK. Bladder consensus conference committee. The World Health Organization/Intemational Society of Urological Pathol-ogy consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22: 1435–48.
   Google Scholar
• Steineck G. Epidemiology and etiology. In: Droller MJ, ed. Bladder cancer: Current diagnosis and treatment. Totowa, NJ: Humana Press 2001 (in press).
   Google Scholar
• Silverman DT, Rothman N, Devesa SS. Epidemiology of bladder cancer. In: Syrigos KN, Skinner DG, eds. Bladder cancer. Biology, diagnosis, and management. New York: Oxford University Press: 1999: 11–55.
   Google Scholar
• Castegnaro M, Chemozemsky I. Endemic nephropathy and urinary tract tumors in the Balkans. Cancer Res 1987; 47: 3608–9.
   Web of Science ®Google Scholar
• Smith AH, Biggs ML, Moore L, Hague R, Steinmaus C, Chung J, et al. Cancer risks from arsenic in drinking water: implications for drinking water standards. In: Chappell WR, Abernathy CO, Calderon RL, eds. Arsenic exposure and health effects. Oxford, UK: Elsevier Science, 1999: 191–9.
   Google Scholar
• Morrison AS, Proppe KH, Verhoek WG, Aoki K, Leck I, Ohno Y, et al. Histologic features of bladder cancer in Boston, USA, Manchester, UK, and Nagoya, Japan. Int J Cancer 1982; 30: 701–5.
   PubMed Web of Science ®Google Scholar
• Stemmermann GN, Yoshizawa CN, Nomura AMY, Kolonel LN. Urothelial cancer in white and Japanese patients in Hawaii: Pathology. J Urol 1990; 144: 44–6.
   PubMed Web of Science ®Google Scholar
• Miller BA, Kolonel LN, Bernstein L, Young Jr JL, Swanson GM, West D, et al Racial/ethnic patterns of cancer in the United States 1988–1992. Bethesda, MD: National Cancer Institute, NIH Publ. No. 96–4104,1996.
   Google Scholar
• D'Avanzo B, Negri E, LaVeechia C, Gramenzi A, Bianchi C, Franceschi S, et al. Cigarette smoking and bladder cancer. Eur J Cancer 1990; 26: 714–8.
   PubMed Web of Science ®Google Scholar
• Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7–33.
   PubMed Web of Science ®Google Scholar
• Zhang Z-F, Steineck G. Epidemiology and etiology of bladder cancer. In: Raghaven D, Scher HI, Leibel SA, Lange PH, eds. Principles and practice of genitourinary oncology. Philadelphia, PA: Lippincott-Raven, 1997: 215–22.
   Google Scholar
• Johansson SL, Cohen SM. Lower urinary tract. In: Damjanov I, Linder J, eds. Anderson's pathology, 10th edn., Vol. 2. St. Louis, MO: Mosby Year Book, Inc., 1996: 2143–65.
   Google Scholar
• Fitzpatrick JM, Reda M. Bladder carcinoma in patients 40 years old or less. J Urol 1986; 135: 53–4.
   PubMed Web of Science ®Google Scholar
• Oyasu R. Epithelial tumors of the lower urinary tract in humans and rodents. Food Chem Toxicol 1995; 33: 747–55.
   PubMed Web of Science ®Google Scholar
• Wiener DP, Koss LG, Sablay B, Freed SZ. The prevalence and significance of Brunn's nests, cystitis cystica and squamous metaplasia in normal bladders. J Urol 1979; 122: 317–21.
   PubMed Web of Science ®Google Scholar
• Shirai T, Fukushima S, Hirose M, Ohshima M, Ito N. Epithelial lesions of the urinary bladder in three hundred and thirteen autopsy cases. Jpn J Cancer Res (Gann) 1987; 78: 1073–80.
   Google Scholar
• El-Bolkainy MN. Schistosomiasis and bladder cancer. In: Bryan GT, Cohen SM, eds. The pathology of bladder cancer, Vol. 1. Boca Raton, FL: CRC Press, 1983: 57–89.
   Google Scholar
• El Sebai I. Cancer of the bladder in Egypt. Proc Int Symp Bilharziasis (Cairo) 1962; 1: 709.
   Google Scholar
• Kantor AF, Hartge P, Hoover RN, Fraumeni Epidemiological characteristics of squamous cell carci-noma and adenocarcinoma of the bladder. Cancer Res 1988; 48: 3853–5.
   PubMed Web of Science ®Google Scholar
• Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JVV, Fraumeni Jr if. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 1984; 119: 510–5.
   PubMed Web of Science ®Google Scholar
• Johansson SL, Cohen SM. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 1997; 13: 291–8.
   PubMed Web of Science ®Google Scholar
• Steineck G, Plato N, Alfredsson L, Norell SE. Industry-related urothelial carcinogens: Application of a job-exposure matrix to census data. Am J Ind Med 1989; 16: 209–24.
   PubMed Web of Science ®Google Scholar
• Matanoski GM, Elliott EA. Bladder cancer epidemiol-ogy. Epidemiol Rev 1981; 3: 203–29.
   PubMed Web of Science ®Google Scholar
• Hueper WC, Wiley FH, Wolfe HD. Experimental pro-duction of bladder tumors in dogs by administration of beta-naphthylamine. J Ind Hyg Toxicol 1938; 20: 46–81.
   Google Scholar
• Augustsson K, Skog K, Jagerstad M, Dickman PW, Steineck G. Dietary heterocyclic amines and cancer of the colon, rectum, bladder and kidney: a population-based study. Lancet 1999; 353: 703–7.
   Google Scholar
• Lijinsky W, Thomas BJ, Kovatch RM. Systemic and local carcinogenesis by directly acting N-nitroso com-pounds given to rats by intravesicular administration. Carcinogenesis 1992; 13: 1101–5.
   Google Scholar
• Bryan GT. Role of tryptophan metabolites in urinary bladder cancer. Am Indust Hyg Assoc J 1969; 30: 27–34.
   PubMedGoogle Scholar
• Hirt DF, Julius AD, Hasegawa R, St John M, Cohen SM. Effect of L-tryptophan excess and vitamin B6 deficiency on urinary bladder cancer promotion. Cancer Res 1987; 47: 1244–50.
   Google Scholar
• IARC working group. Saccharin and its salts. In: IARC monographs on the evaluation of carcinogenic risks to humans. Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances, Vol. 73. Lyons, France: World Health Organization IARC, 1999: 517–624.
   Google Scholar
• IARC working group. Cyclamates. In: IARC mono-graphs on the evaluation of carcinogenic risks to humans. Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances, Vol. 73. Lyons, France: World Health Organization IARC, 1999: 195–222.
   Google Scholar
• Cohen SM, Ellwein LB. Relationship of DNA adducts derived from 2-acetylaminofluorene to cell proliferation and the induction of rodent liver and bladder tumors. Toxicol Pathol 1995; 23: 136–42.
   PubMed Web of Science ®Google Scholar
• Cohen SM. Cell proliferation and carcinogenesis. Drug Metab Rev 1998; 30: 339–57.
   PubMed Web of Science ®Google Scholar
• Auerbach O, Garfinkel L. Histologic changes in the urinary bladder in relation to cigarette smoking and use of artificial sweeteners. Cancer 1989; 64: 983–7.
   PubMed Web of Science ®Google Scholar
• Hartge P, Hoover R, Kantor A. Bladder cancer risk and pipes, cigars and smokeless tobacco. Cancer 1985; 55: 901–6.
   Google Scholar
• Cole P, Monson RR, Haning H, Friedell GH. Smoking and cancer of the lower urinary tract. N Engl J Med 1971; 284: 129–34.
   PubMed Web of Science ®Google Scholar
• Thomas DB, Uhl CN, Hartge P. Bladder cancer and alcoholic beverage consumption. Am J Epidemiol 1983; 118: 720–7.
   Google Scholar
• IARC working group. Some metals and metallic compounds. In: IARC monographs on the evaluation of carcinogenic risks to humans, Vol. 23. Lyons, France: World Health Organization IARC, 1980: 39–141.
   Google Scholar
• van Gernert M, Eldan M. Chronic carcinogenicity assessment of cacodylic acid. Paper presented at 3rd International Conference on Arsenic Exposure and Health Effects, San Diego, CA.
   Google Scholar
• Wei M, Wanabuchi H, Yamamoto S, Li W, Fukushima S. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 1999; 20: 1873–6.
   Google Scholar
• Yamamoto S, Wanibuchi H, Hon i T-A, Yano Y, Matsui-Yuasa I, Otani S, et al. Possible carcinogenic potential of dimethylarsinic acid as assessed in rat in vivo models: a review. Mutat Res 1997; 386: 353–61.
   Google Scholar
• Wang Z, Rossman TG. The carcinogenicity of arsenic. In: Chang LW, ed. Toxicology of metals. Boca Raton, FL: CRC Press, 1996: 219–27.
   Google Scholar
• Arnold LL, Cano M, St John M, Eldan M, van Gernert M, Cohen SM. Effects of dimethylarsinic acid on the urine and urothelium of rats. Carcinogenesis 1999; 20: 2171–9.
   PubMed Web of Science ®Google Scholar
• Morris RD, Audet A-M, Angelillo IF, Chalmers TC, Mosteller F. Chlorination, chlorination by-products, and cancer: A meta-analysis. Am J Publ Health 1996; 82: 955–63.
   Google Scholar
• Michaud DS, Spiegelman D, Clinton SK, Rimm EB, Curhan GC, Willett WC, et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med 1999; 340: 1390–7.
   PubMed Web of Science ®Google Scholar
• Sugita M, Yoshida O, Miyakawa M, Okada Y, Oshiro K, Yamaguichi N, et al. Mortality rates by causes of deaths in the area aggregated by dyeing factories Kyoto. Sangyo Igaku 1980; 22: 40–9.
   PubMedGoogle Scholar
• IARC working group. Coffee. In: IARC monographs on the evaluation of carcinogenic risks to humans. Coffee, tea, meat, methylxanthines and methylglyoxal, Vol. 51. Lyons, France: World Health Organization IARC, 1991: 41–206.
   Google Scholar
• Boice JD, Engholm G, Kleinerman RA, Blettner M, Stovall M, Lisco H, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988; 116: 3–55.
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Romanenko A, Wei M, Masuda C, Zaparin W, Vinnichenko W, et al. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Cancer Res 1999; 59: 3606–9.
   PubMed Web of Science ®Google Scholar
• Paile W. Comment on Yamamoto et al Cancer Res 2000; 60: 1146.
   PubMed Web of Science ®Google Scholar
• Burin GI, Gibb HJ, Hill RN. Human bladder cancer: Evidence for a potential irritation-induced mechanism. Food Chem Toxicol 1995; 33: 785–95.
   Google Scholar
• Rodent bladder carcinogenesis working group. Urinary bladder carcinogenesis: implications for risk assessment. Food Chem Toxicol 1995; 33: 797–802.
   PubMed Web of Science ®Google Scholar
• Clayson DB, Fishbein L, Cohen SM. The effect of stones and other physical factors on the induction of rodent bladder cancer. Food Chem Toxicol 1995; 33: 771–84.
   Google Scholar
• DeSesso JM. Anatomical relationships of urinary bladders compared: Their potential role in the develop-ment of bladder tumors in humans and rats. Food Chem Toxicol 1995; 33: 705–14.
   PubMed Web of Science ®Google Scholar
• Spruck CHI, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994; 54: 784–8.
   Google Scholar
• Jones PA, Droller MJ. Pathways of development and progression in bladder cancer: New correlations between clinical observations and molecular mechanisms. Semin Urol 1993; 11: 177–92.
   PubMedGoogle Scholar
• Claude J, Kunze E, Frentzel-Beyme R, Schneider J, Schubert H. Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 1986; 124: 578–86.
   Google Scholar
• Chyou PA, Nomura AMY, Stemmermann GN. A pros-pective study of diet, smoking, and lower urinary tract cancer. Ann Epidemiol 1993; 3: 211–6.
   Google Scholar
• Levine LA, Richie IP. Urological complications of cyclophosphamide. J Urol 1989; 141: 1063–9.
   PubMed Web of Science ®Google Scholar
• Koss LG, Melamed MR, Kelly RE. Further cytologic and histologic studies of bladder lesions in workers exposed to para-aminodiphenyl: Progress Report. J Natl Cancer Inst 1969; 43: 233–43.
   Google Scholar
• Kramer AA, Graham S, Burnett WS. Familial aggrega-tion of bladder cancer stratified by smoking status. Epidemiology 1991; 2: 145–8.
   Google Scholar
• Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF. Role of aromatic amine acetyltransferases, NAT I and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 1995; 55: 5230–7.
   Google Scholar
• Lower GM, Nilsson T, Nelson CE, Wolfe H, Gamsky TF, Bryan GT. N-acetyltransferase phenotype and risk in urinary bladder cancer. Approaches in molecular epidemiology. Preliminary results in Sweden and Den-mark. Environ Health Perspect 1979; 29: 71–9.
   PubMed Web of Science ®Google Scholar
• Cartwright RA, Rogers HJ, Barham-Hall D, Glashan RW, Ahmad RA, Higgins E, et al. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 1982: 842–6.
   Google Scholar
• Bartsch H, Malaveile C, Friesen M, Kadlubar FF, Vineis P. Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer 1993; 29A: 1199–207.
   Google Scholar
• Horn EP, Tucker MA, Lambert G, Silverman D, Zametkin D, Sinha R, et al. A study of gender-based cytochrom P4501A2 variability: A possible mechanism for the male excess of bladder cancer. Cancer Epidemiol Biomarkers Prey 1995; 4: 529–33.
   PubMed Web of Science ®Google Scholar
• Silverman DT, Monison AS, Devesa SS. Bladder. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiol-ogy and prevention. New York: Oxford University Press, 1996: 1142–79.
   Google Scholar
• Farker K, Lehmann MH, Kastner R, Hoffmann A, Janitzky V, Schubert J, et al. CYP2E1 genotyping in renal cell/urothelial cancer patients in comparison with control populations. Int J Clin Pharmacol Ther 1998; 36: 463–8.
   PubMed Web of Science ®Google Scholar
• Brockmoller J, Kerb R, Drakoulis N, Staffeldt B, Roots I. Glutathione 5-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: A case-control study. Cancer Res 1994; 54: 4103–11.
   Google Scholar
• Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, et al. Human glutathione 5-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics 1999; 9: 165–69.
   PubMedGoogle Scholar
• Penn I. Tumors of the immunocompromised patient. Ann Rev Med 1988; 39: 63–73.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Fukushima S, Tsuda H, Murasaki G, Ito N. Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats. Jpn J Cancer Res 1978; 69: 773–9.
   Google Scholar
• Bruemmer B, White E, Vaughn TL, Cheney CL. Nutrient intake in relation to bladder cancer among middle-aged men and women. Am J Epidemiol 1996; 144: 485–95.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Wittenberg JF, Bryan GT. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-[4-(5-nitro-2-fury1)-2-thia-zolyl]formamide. Cancer Res 1976; 36: 2334–9.
   Google Scholar
• Steineck G, Hagman U, Gerhardsson M, Norell SE. Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-1987. Int J Cancer 1990; 45: 1006–11.
   Google Scholar
• La Vecchia C, Negri E. Nutrition and bladder cancer. Cancer Causes Control. 1996; 7: 95–100.
   PubMed Web of Science ®Google Scholar
• Hows JM, Mehta A, Ward L, Woods K, Perez R, Gordon MY, et al. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemor-rhagic cystitis in marrow transplantation: A prospective randomised study. Br J Cancer 1984; 50: 753–6.
   PubMed Web of Science ®Google Scholar